- Filed
- Dec 10, 2025 12:00 AM ET
- Period of report
- —
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q3 2025 · Dec 4, 2025 | 89.68M sh |
| Shares Diluted | Q3 2025 · Oct 31, 2025 | 91.29M sh |
| Shares Diluted | Q3 2025 · Oct 31, 2025 | 91.96M sh |
| Shares Diluted | Q3 2025 · Oct 31, 2024 | 93.86M sh |
| Shares Diluted | Q3 2025 · Oct 31, 2024 | 94.51M sh |
| Stock Repurchased | Q3 2025 · Oct 31, 2025 | $151.94M |
| Stock Repurchased | Q3 2025 · Oct 31, 2024 | $52.26M |
| Capex | Q3 2025 · Oct 31, 2025 | $191.45M |
| Capex | Q3 2025 · Oct 31, 2024 | $144.05M |
| Operating Cash Flow | Q3 2025 · Oct 31, 2025 | $312.19M |
| Operating Cash Flow | Q3 2025 · Oct 31, 2024 | $182.36M |
| Cash And Equivalents | Q3 2025 · Oct 31, 2025 | $306.6M |
| Cash And Equivalents | Q3 2025 · Jan 31, 2025 | $290.48M |
| Cash And Equivalents | Q3 2025 · Oct 31, 2024 | $182.52M |
| Stockholders Equity | Q3 2025 · Oct 31, 2025 | $2.7B |
| Stockholders Equity | Q3 2025 · Jul 31, 2025 | $2.58B |
| Stockholders Equity | Q3 2025 · Jan 31, 2025 | $2.47B |
| Stockholders Equity | Q3 2025 · Oct 31, 2024 | $2.35B |
| Stockholders Equity | Q3 2025 · Jul 31, 2024 | $2.24B |
| Stockholders Equity | Q3 2025 · Jan 31, 2024 | $2.11B |
| Current Liabilities | Q3 2025 · Oct 31, 2025 | $1.17B |
| Current Liabilities | Q3 2025 · Jan 31, 2025 | $1.08B |
| Current Liabilities | Q3 2025 · Oct 31, 2024 | $1.13B |
| Total Liabilities | Q3 2025 · Oct 31, 2025 | $2.2B |
| Total Liabilities | Q3 2025 · Jan 31, 2025 | $2.05B |
| Total Liabilities | Q3 2025 · Oct 31, 2024 | $2.13B |
| Current Assets | Q3 2025 · Oct 31, 2025 | $1.76B |
| Current Assets | Q3 2025 · Jan 31, 2025 | $1.49B |
| Current Assets | Q3 2025 · Oct 31, 2024 | $1.64B |
| Total Assets | Q3 2025 · Oct 31, 2025 | $4.91B |
| Total Assets | Q3 2025 · Jan 31, 2025 | $4.52B |
| Total Assets | Q3 2025 · Oct 31, 2024 | $4.49B |
| Eps Diluted | Q3 2025 · Oct 31, 2025 | $1.28 |
| Eps Diluted | Q3 2025 · Oct 31, 2025 | $4.01 |
| Eps Diluted | Q3 2025 · Oct 31, 2024 | $1.10 |
| Eps Diluted | Q3 2025 · Oct 31, 2024 | $2.99 |
| Eps Basic | Q3 2025 · Oct 31, 2025 | $1.30 |
| Eps Basic | Q3 2025 · Oct 31, 2025 | $4.08 |
| Eps Basic | Q3 2025 · Oct 31, 2024 | $1.12 |
| Eps Basic | Q3 2025 · Oct 31, 2024 | $3.04 |
| Sga Expense | Q3 2025 · Oct 31, 2025 | $419.01M |
| Sga Expense | Q3 2025 · Oct 31, 2025 | $1.17B |
| Sga Expense | Q3 2025 · Oct 31, 2024 | $368.63M |
| Sga Expense | Q3 2025 · Oct 31, 2024 | $1.05B |
| Net Income | Q3 2025 · Oct 31, 2025 | $116.44M |
| Net Income | Q3 2025 · Oct 31, 2025 | $368.65M |
| Net Income | Q3 2025 · Oct 31, 2024 | $102.91M |
| Net Income | Q3 2025 · Oct 31, 2024 | $282.16M |
| Operating Income | Q3 2025 · Oct 31, 2025 | $144.32M |
| Operating Income | Q3 2025 · Oct 31, 2025 | $446.93M |
| Operating Income | Q3 2025 · Oct 31, 2024 | $128.69M |
| Operating Income | Q3 2025 · Oct 31, 2024 | $348.45M |
| Gross Profit | Q3 2025 · Oct 31, 2025 | $563.33M |
| Gross Profit | Q3 2025 · Oct 31, 2025 | $1.62B |
| Gross Profit | Q3 2025 · Oct 31, 2024 | $497.32M |
| Gross Profit | Q3 2025 · Oct 31, 2024 | $1.4B |
| Cost Of Revenue | Q3 2025 · Oct 31, 2025 | $964.03M |
| Cost Of Revenue | Q3 2025 · Oct 31, 2025 | $2.74B |
| Cost Of Revenue | Q3 2025 · Oct 31, 2024 | $864.54M |
| Cost Of Revenue | Q3 2025 · Oct 31, 2024 | $2.51B |
| Revenue | Q3 2025 · Oct 31, 2025 | $1.53B |
| Revenue | Q3 2025 · Oct 31, 2025 | $4.36B |
| Revenue | Q3 2025 · Oct 31, 2024 | $1.36B |
| Revenue | Q3 2025 · Oct 31, 2024 | $3.91B |